Cipher Pharmaceuticals Inc.
TSX:CPH.TO · Toronto Stock Exchange
+$0.15 today
Vol 0.01M · Avg 0.03M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
22.1%
avg -4.3%
ROIC
12.8%
avg 9.4%
ROA
17.8%
avg 6.9%
Analysis
ROE is currently the strongest return metric at 22.1% versus its period average of -4.3%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Bryan Jacobs | President | $703,500.00 | — | — | — | — |
Ryan Mailling | Chief Financial Officer | $287,500.00 | — | — | — | — |
Craig J. Mull | Interim Chief Executive Officer & Chairman of the Board | $150,000.00 | — | — | — | — |
Emilio Presti | Director of Sales & Marketing | — | — | — | — | — |
Shengnan Guo | Corporate Controller | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -11.2% | +21.1% (15yr)1 analysts |
| Revenue | N/A | N/A | +59.4% | +5.1% (15yr)1 analysts |
| Net Income | N/A | N/A | -11.6% | +21.3% (15yr)1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +59.4% over three years. Forward estimates point to Net Income at +21.3% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Knight Therapeutics Inc.
TSX:GUD.TO
$922.89M
NervGen Pharma Corp.
NGEN.V
$407.94M
Spectral Medical Inc.
TSX:EDT.TO
$399.05M
Fennec Pharmaceuticals Inc.
TSX:FRX.TO
$360.97M
High Tide Inc.
HITI.V
$289.97M
TerrAscend Corp.
TSX:TSND.TO
$283.25M
Canopy Growth Corporation
TSX:WEED.TO
$243.53M
Aurora Cannabis Inc.
TSX:ACB.TO
$233.64M
OrganiGram Holdings Inc.
TSX:OGI.TO
$189.69M
Jushi Holdings Inc.
JUSH.CN
$129.80M
Who manages CPH.TO?
Cipher Pharmaceuticals Inc. (CPH.TO) lists 5 active executives. The top listed executive is Emilio Presti, Director of Sales & Marketing.
Explore More
Continue the stock analysis
Jump to another research area for this company.